Attention Long-Term Shareholders of Insulet Corporation (NASDAQ: PODD); Navan, Inc. (NASDAQ: NAVN); Via Transportation, Inc. (NYSE: VIA); and ZoomInfo Technologies, Inc. (NASDAQ: GTM): Grabar Law Office is Investigating Claims on Your Behalf

This is a legal warning, not an investable signal—serious red flags, no upside disclosed.

What the company is saying

The companies named—Insulet Corporation, Navan, Inc., Via Transportation, Inc., and ZoomInfo Technologies, Inc.—are not directly communicating to investors in this announcement; instead, the narrative is constructed by Grabar Law Office, which is soliciting shareholders for participation in class action lawsuits. The core message is that these companies, through their officers and directors, allegedly breached fiduciary duties and made materially false or misleading statements, particularly around manufacturing controls, financial disclosures, and business prospects. The language is legalistic and accusatory, emphasizing alleged failures in oversight, disclosure, and governance, with repeated references to 'materially false and misleading' statements and 'omissions' in IPO documents. The announcement highlights specific negative events, such as voluntary medical device corrections for Insulet, a decline in key revenue metrics and stock price for Via Transportation, and alleged concealment of business deterioration at ZoomInfo. There is no attempt to present a balanced or positive view; the focus is entirely on alleged wrongdoing and investor harm. Notably, the announcement buries any discussion of operational context, business fundamentals, or management's perspective, offering no defense or explanation from the companies themselves. The tone is stern, urgent, and procedural, designed to mobilize shareholders to join legal actions rather than to reassure or inform about business prospects. The only named individual is Joshua H. Grabar, an attorney leading the investigations, whose involvement signals legal seriousness but does not carry operational or institutional investment implications. This narrative fits a legal solicitation strategy, not an investor relations approach, and is intended to maximize participation in litigation rather than to shape market perception of the companies' future.

What the data suggests

The disclosed numbers are sparse and almost entirely negative, with the only concrete financial data relating to Via Transportation, Inc. Specifically, Via reported a decline in Platform Annual Run-Rate Revenue per customer for the first time in eight quarters, which was followed by a series of sharp stock price declines: nearly 13% after Q3 2025 results, nearly 8% after Q4 2025 results, and an additional 17% after Q1 2026 results, leaving the stock nearly 70% below its IPO price. These figures indicate a clear and accelerating deterioration in both operational performance and investor confidence. For Insulet Corporation, the only quantitative disclosures are the dates and nature of voluntary medical device corrections, with no revenue, cost, or impact figures provided. Navan, Inc. and ZoomInfo Technologies, Inc. are discussed only in terms of alleged omissions and misleading statements, with no actual financial or operational metrics disclosed. There is no evidence that any prior targets or guidance have been met; in fact, the absence of such data suggests either non-disclosure or underperformance. The quality of the financial disclosures is poor—key metrics such as revenue, profit, margins, or customer numbers are missing, and the only available data points are negative stock price reactions and qualitative statements about business headwinds. An independent analyst would conclude that the trajectory for Via Transportation is sharply negative, with no evidence of stabilization or turnaround, while the other companies are facing serious legal and reputational risks with no counterbalancing operational data.

Analysis

The announcement is a legal notice regarding investigations and class action lawsuits against several companies, with a focus on alleged disclosure failures and governance issues. The tone is negative, but the language is factual and procedural, not promotional or exaggerated. There are no forward-looking claims of improvement or benefit; the only forward-looking statement is that regulatory issues will continue to limit Via Transportation’s growth in Germany, which is a negative projection. No capital outlays, growth initiatives, or aspirational targets are discussed. The document lacks any positive spin or narrative inflation, and there is no attempt to overstate progress or prospects. The absence of financial or operational metrics means there is no measurable progress to inflate, and the announcement does not attempt to bridge any gap between perception and reality. All claims are either allegations or disclosures of realised negative events.

Risk flags

• ●Operational risk is acute for Via Transportation, Inc., as evidenced by the first decline in Platform Annual Run-Rate Revenue per customer in eight quarters and the inability to sell its full platform in Germany. This signals a breakdown in the company's growth model and exposes it to further revenue contraction.
• ●Regulatory risk is material, particularly for Via Transportation, which faces ongoing headwinds in Germany that have already limited its ability to execute its 'land and expand' strategy. The persistence of these issues, with no disclosed resolution, threatens both current operations and future growth.
• ●Disclosure risk is high across all companies named, with allegations of materially false or misleading statements and omissions in IPO documents and public filings. For investors, this raises the possibility of further negative surprises and undermines confidence in management's communications.
• ●Financial risk is pronounced for Via Transportation, whose stock has declined nearly 70% from its IPO price in less than a year, reflecting both operational underperformance and market loss of faith. Such a steep and rapid decline increases the risk of capital impairment and potential liquidity issues.
• ●Legal risk is front and center, as all four companies are under active investigation for securities fraud and breach of fiduciary duty. The outcome of these class actions is uncertain, but the process itself can be costly, distracting, and damaging to reputation and valuation.
• ●Data quality risk is significant, as the announcement provides no concrete financial or operational metrics for Insulet, Navan, or ZoomInfo, making it impossible for investors to independently assess the scale or trajectory of the alleged problems. This opacity increases uncertainty and risk.
• ●Forward-looking risk is present, particularly for Via Transportation, where the only forward-looking statement is negative—regulatory issues are expected to continue limiting growth. The lack of any disclosed remediation plan or timeline compounds the risk.
• ●Execution risk is implicit, as the companies face multiple simultaneous challenges—regulatory, operational, legal, and reputational—with no evidence of effective management response or turnaround strategy. The absence of disclosed corrective actions or milestones leaves investors exposed to further downside.

Bottom line

For investors, this announcement is a legal solicitation, not a business update or investment thesis. The only actionable information is that all four companies—Insulet, Navan, Via Transportation, and ZoomInfo—are under investigation for serious alleged failures in disclosure, governance, and operational controls. The only concrete financial data relates to Via Transportation, which has suffered a catastrophic 70% decline in share price since its IPO, driven by operational underperformance and regulatory setbacks in Germany. There is no evidence of stabilization, turnaround, or credible management response from any of the companies. The absence of financial or operational metrics for Insulet, Navan, and ZoomInfo means investors are flying blind regarding the true scale of the alleged problems. The involvement of Joshua H. Grabar as lead attorney signals legal gravity but does not imply any operational or institutional investment insight. To change this assessment, the companies would need to disclose detailed, audited financials, operational metrics, and a credible remediation plan addressing the specific allegations. Investors should watch for any future disclosures of revenue, profit, customer retention, regulatory resolutions, or management changes in the next reporting period. This announcement is not a buy or hold signal; it is a clear warning to monitor for further downside and to be extremely cautious. The single most important takeaway is that these companies are facing immediate, material risks with no disclosed path to resolution—this is a red flag, not an opportunity.

Announcement summary

(NASDAQ: PODD) Insulet Corporation is under investigation by Grabar Law Office regarding whether certain officers and directors breached fiduciary duties, with claims focusing on defective manufacturing controls and procedures, and two voluntary Medical Device Corrections disclosed on March 12, 2026 and May 26, 2026 for Omnipod® 5, Omnipod Dash®, and Omnipod® Insulin Management System (Omnipod Eros) Pods. (NASDAQ: NAVN) Navan, Inc. is being investigated for alleged omissions in its October 30, 2025 IPO documents, specifically regarding decelerating revenue growth and increased sales and marketing spending, with the investigation focusing on failures in oversight, disclosure, and controls. (NYSE: VIA) Via Transportation, Inc. is under investigation following allegations that its IPO offering documents were materially false and/or misleading, with key facts including a decline in Platform Annual Run-Rate Revenue per customer disclosed on November 13, 2025, and stock price declines of nearly 13%, nearly 8%, and an additional 17% on subsequent disclosures, particularly related to regulatory issues in Germany. (NASDAQ: GTM) ZoomInfo Technologies, Inc. is being investigated for allegedly making false and/or misleading statements about business growth, customer retention, and AI product adoption, while allegedly concealing deterioration in its legacy seat-based subscription business and a shift toward consumption-based pricing models. The company projects that regulatory issues will continue to limit Via Transportation’s growth in Germany, as reported in its 2026 first quarter financial results. No specific revenue, profit, or loss figures are disclosed for any company in the announcement. The investigations are based on recently filed federal securities fraud class action complaints and focus on alleged failures in disclosure, oversight, and governance.

Disagree with this article?